MGAT5 Protein, Human (HEK293, His)

Customer Review

Based on 1 Customer Validation

The MGAT5 protein regulates the cytoskeleton, adhesion, migration, and signaling. MGAT5 Protein, Human (HEK293, His) is the recombinant human-derived MGAT5 protein, expressed by HEK293 , with C-His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The MGAT5 protein regulates the cytoskeleton, adhesion, migration, and signaling. MGAT5 Protein, Human (HEK293, His) is the recombinant human-derived MGAT5 protein, expressed by HEK293 , with C-His labeled tag.

Background

MGAT5 protein is a key enzyme that catalyzes the addition of N-acetylglucosamine (GlcNAc) in beta 1-6 linkage to the alpha-linked mannose of biantennary N-linked oligosaccharides. This catalytic activity is crucial for the biosynthesis of branched, complex-type N-glycans found on various proteins, including EGFR, TGFR (TGF-beta receptor), and CDH2. Through its involvement in complex N-glycan biosynthesis, MGAT5 plays a pivotal role in cellular signaling pathways, actin cytoskeleton reorganization, cell-cell adhesion, and cell migration. Notably, MGAT5-dependent EGFR N-glycosylation prolongs EGFR signaling by preventing rapid endocytosis. MGAT5 is also essential for efficient interactions between TGFB1 and its receptor, enhancing intracellular signaling pathways activated by growth factors like FGF2, PDGF, IGF, TGFB1, and EGF. Additionally, MGAT5-mediated CDH2 N-glycosylation inhibits homotypic cell-cell adhesion, influencing downstream signaling pathways and promoting cell migration. In the immune response, MGAT5-dependent TCR N-glycosylation limits TCR clustering and dampens TCR-mediated responses to antigens, contributing to normal leukocyte evasion and accumulation at inflammatory sites. Moreover, MGAT5 inhibits monocyte attachment to vascular endothelium and subsequent diapedesis, while also promoting proliferation of endothelial cells and angiogenesis by facilitating the release of FGF2 from the extracellular matrix. In summary, MGAT5 emerges as a multifaceted regulator with significant implications in cellular processes, immune responses, and angiogenesis.

Verified Bioactivity

Measured in a cell proliferation assay using MDA-MB-231 cells. The ED50 for this effect is <0.1 μg/mL, corresponding to a activity is >1×10^4 units/mg.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - Cell-Based Assay

    Bioactivity - Cell-Based Assay

    Measured in a cell proliferation assay using MDA-MB-231 cells. The ED50 for this effect is 0.01096 μg/mL, corresponding to a specific activity is 9.124×104 units/mg.

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • MGAT5 (L189-L741)
      Accession # Q09328
    • His
    • C-term
  • Protein Length

    Partial

  • Synonyms

    MGAT5; Mannoside Acetylglucosaminyltransferase 5; Alpha-1,6-Mannosylglycoprotein 6-Beta-N-Acetylglucosaminyltransferase; N-Acetylglucosaminyl-Transferase V; GNT-V; GlcNAc-T V; Alpha-1,6-Mannosylglycoprotein 6-Beta-N-Acetylglucosaminyltransferase A; Alpha-

  • AA Sequence

    LSEVENWCPHLPWRAKNPYEEADHNSLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMKKVVGNRSGCPTVGDRIVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL

  • Molecular Weight

    Approximately 60-65 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

Lyophilized from a 0.22 μm filtered solution of PBS, 5% trehalose, mannitol, 0.01% Tween 80, pH 7.4.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00